In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Allan Coukell, chief government affairs officer at Civica, said manufacturing has begun at the company's new pharmaceutical plant in Virginia but there is no timeline for when the first insulin -- a ...

This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from the pricier kind. Many diabetes patients have experienced lowered drug ...

Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...